肺癌患者静脉血栓风险评估工具的研究进展  

Research Progress of Venous Thromboembolism Risk Assessment Tools in Lung Cancer Patients

作　　者：周梓轩 文彦[1] 徐薇薇 谢沛希[1] 刘佳玲 Zhou Zixuan;Wen Yan;Xu Weiwei;Xie Peixi;Liu Jialing(Department of Thoracic Oncology,Sichuan Clinical Research Center for Cancer,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China)

机构地区：[1]四川省肿瘤医院·研究所,四川省肿瘤临床医学研究中心,四川省癌症防治中心,电子科技大学附属肿瘤医院胸部肿瘤内科,成都610041

出　　处：《肿瘤预防与治疗》2025年第3期248-253,共6页Journal of Cancer Control And Treatment

基　　金：四川省卫生健康信息中心科研课题(编号:2023ZXKY06007)。

摘　　要：静脉血栓栓塞症(venous thromboembolism,VTE)指静脉内形成血凝块,导致深静脉血栓形成,严重者可形成肺栓塞,是肺部恶性肿瘤的最常见并发症之一,也是肺癌患者医院内非预期死亡的重要危险因素。因此,要对VTE进行早期的预防及干预,需寻找合适的评估工具对患病风险进行精准的评估和风险分层,针对低中高危患者制定相应的治疗管理方案,预防早期血栓事件发生,使患者获益。本文对国内外肺癌相关VTE的风险评估工具进行综述,以期为临床工作者推荐合适的VTE风险评估工具,提供适宜的实践指导依据。Venous thromboembolism(VTE)refers to the formation of blood clots in the veins,which can lead to deep vein thrombosis.In severe cases,it can result in pulmonary embolism.VTE is one of the most common complications in lung cancer patients and a significant risk factor for unexpected hospital deaths.Therefore,to achieve early prevention and intervention for VTE,it is necessary to identify appropriate assessment tools for accurate evaluation and risk stratification.Tailored treatment and management plans should be developed for low-,intermediate-,and high-risk patients to prevent early thrombotic events and improve patient outcomes.This article reviews VTE risk assessment tools related to lung cancer,both domestically and internationally,to provide practical guidance for clinical practitioners.

关 键 词：肺癌 静脉血栓栓塞症 风险预测 评估工具 

分 类 号：R734.2[医药卫生—肿瘤]